Dihydropyridine calcium channel blocker. Prepn: Y. Sato, BE 879263; idem, US 4338322 (1980, 1982 both to Fujisawa). Structural studies: A. Miyamae et al., Chem. Pharm. Bull. 34, 3071 (1986). Determn in plasma and urine: Y. Tokuma et al., J. Chromatogr. 415, 156 (1987). Preliminary pharmacokinetics and resolution of enantiomers: eidem, J. Pharm. Sci. 76, 310 (1987). Pharmacokinetics in rabbits: Y. Nezasa et al., Kankyo Igaku Kenkyusho Nenpo 38, 200 (1987), C.A. 107, 89273q (1987). Mode of action: P. A. Molyvdas, N. Sperelakis, J. Cardiovasc. Pharmacol. 8, 449 (1986). Cardiovascular effects: G. J. Gross et al., Gen. Pharmacol. 14, 677 (1983). Clinical evaluation in hypertension: K. Mizuno et al., Res. Commun. Chem. Pathol. Pharmacol. 52, 3 (1986).
Antihypertensive; antianginal.
Antianginal; Antihypertensive; Dihydropyridine Derivatives; Calcium Channel Blocker; Dihydropyridine Derivatives